Fennec Pharmaceuticals (TSE:FRX) Stock Crosses Above 50 Day Moving Average – Here’s Why

Fennec Pharmaceuticals Inc. (TSE:FRX) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$9.29 and traded as high as C$9.57. Fennec Pharmaceuticals shares last traded at C$9.57, with a volume of 5,399 shares trading hands.

Fennec Pharmaceuticals Stock Performance

The stock’s 50 day moving average is C$9.29 and its two-hundred day moving average is C$8.00. The stock has a market capitalization of C$184.55 million, a price-to-earnings ratio of -162.11 and a beta of 0.25. The company has a current ratio of 7.80, a quick ratio of 10.17 and a debt-to-equity ratio of -620.83.

Insider Activity

In other news, Director Rostislav Christov Raykov sold 7,569 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of C$9.71, for a total value of C$73,503.54. Insiders have sold a total of 21,186 shares of company stock worth $196,017 over the last three months. Corporate insiders own 16.20% of the company’s stock.

Fennec Pharmaceuticals Company Profile

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.